A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy

Mise à jour : Il y a 4 ans
Référence : NCT00478023

Femme Homme

Extrait

The main objective of this study is to demonstrate the efficacy and safety of multiple-dose application of three different oral doses of CG5503 IR (tapentadol immediate release) compared to placebo in women undergoing abdominal hysterectomy.


Critère d'inclusion

  • Hysterectomy ,Postoperative


Liens